UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 13 | Issue 3 | March 2026

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 12 Issue 12
December-2025
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2512225


Registration ID:
573010

Page Number

c210-c224

Share This Article


Jetir RMS

Title

NEURODEGENERATIVE DISORDERS: A COMPREHENSIVE INSIGHT INTO CURRENT AND EMERGING THERAPEUTIC APPROACHES

Abstract

Neurodegenerative disorders (NDs) embrace a collective group of conditions portrayed by the gradual loss of neurons, leading to dementia, motor dysfunction, and other neurological defects. Major NDs include Alzheimer's Disease (AD), Parkinson’s Disease (PD), Huntington’s Disease (HD), and Amyotrophic Lateral Sclerosis (ALS), each carrying distinct clinical manifestations and pathogenic mechanisms such as protein aggregation, oxidative stress, and neuroinflammation. Globally, neurological diseases affect billions, with AD and PD reported as ubiquitous among other NDs, seemingly increasing in number with the progression of age. Though conventional drug therapies offer symptomatic relief, their effectiveness is hampered by limited brain drug delivery and the blood-CSF barrier, followed by different adverse reactions. Advanced therapeutic interventions, including monoclonal antibodies, precision medicine, advanced drug delivery systems, and gene and stem cell therapies, promise to slow disease progression. However, challenges, including late diagnosis and high out-of-pocket expenses, increase the risk of incidence. Emerging interventions like deep brain stimulation and novel site-specific drug delivery techniques show promise for PD and AD, as well as supportive care for less common NDs such as HD and FTD. Despite these advances, early diagnosis and effective disease-modifying treatments remain critical unmet needs in managing neurodegeneration at a global scale.

Key Words

Alzheimer’s Disease, Parkinson’s Disease, Precision medicine, Targeted therapy, Deep brain stimulation

Cite This Article

"NEURODEGENERATIVE DISORDERS: A COMPREHENSIVE INSIGHT INTO CURRENT AND EMERGING THERAPEUTIC APPROACHES", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.12, Issue 12, page no.c210-c224, December-2025, Available :http://www.jetir.org/papers/JETIR2512225.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"NEURODEGENERATIVE DISORDERS: A COMPREHENSIVE INSIGHT INTO CURRENT AND EMERGING THERAPEUTIC APPROACHES", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.12, Issue 12, page no. ppc210-c224, December-2025, Available at : http://www.jetir.org/papers/JETIR2512225.pdf

Publication Details

Published Paper ID: JETIR2512225
Registration ID: 573010
Published In: Volume 12 | Issue 12 | Year December-2025
DOI (Digital Object Identifier):
Page No: c210-c224
Country: ETTUMANOOR/ KOTTAYAM, KERALA, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

00016

Print This Page

Current Call For Paper

Jetir RMS